RU2002116180A - A method for the treatment of senile macular retinal dystrophy - Google Patents

A method for the treatment of senile macular retinal dystrophy Download PDF

Info

Publication number
RU2002116180A
RU2002116180A RU2002116180/14A RU2002116180A RU2002116180A RU 2002116180 A RU2002116180 A RU 2002116180A RU 2002116180/14 A RU2002116180/14 A RU 2002116180/14A RU 2002116180 A RU2002116180 A RU 2002116180A RU 2002116180 A RU2002116180 A RU 2002116180A
Authority
RU
Russia
Prior art keywords
treatment
senile macular
retinal dystrophy
macular retinal
retina
Prior art date
Application number
RU2002116180/14A
Other languages
Russian (ru)
Inventor
Галина Ивановна Должич
Светлана Федоровна Савченко
Original Assignee
Галина Ивановна Должич
Светлана Федоровна Савченко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Галина Ивановна Должич, Светлана Федоровна Савченко filed Critical Галина Ивановна Должич
Priority to RU2002116180/14A priority Critical patent/RU2002116180A/en
Publication of RU2002116180A publication Critical patent/RU2002116180A/en

Links

Claims (1)

Способ лечения сенильной макулярной дистрофии путем лазерного воздействия на сетчатку, отличающийся тем, что у больных предварительно определяют уровень фермента супероксиддисмутазы, гликозилированного гемоглобина и иммуннорегуляторного индекса, и при ухудшении этих показателей на 25% и более по отношению к физиологической норме, назначают милдронат по 5 мл внутривенно в течение 10 дней, после чего производят лазерное воздействие на сетчатку.A method of treating senile macular dystrophy by laser irradiation of the retina, characterized in that the level of superoxide dismutase enzyme, glycosylated hemoglobin and immunoregulatory index is preliminarily determined in patients, and when these indicators worsen by 25% or more with respect to the physiological norm, 5 ml of mildronate is prescribed intravenously for 10 days, after which they produce a laser effect on the retina.
RU2002116180/14A 2002-06-19 2002-06-19 A method for the treatment of senile macular retinal dystrophy RU2002116180A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002116180/14A RU2002116180A (en) 2002-06-19 2002-06-19 A method for the treatment of senile macular retinal dystrophy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002116180/14A RU2002116180A (en) 2002-06-19 2002-06-19 A method for the treatment of senile macular retinal dystrophy

Publications (1)

Publication Number Publication Date
RU2002116180A true RU2002116180A (en) 2004-01-20

Family

ID=36050445

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002116180/14A RU2002116180A (en) 2002-06-19 2002-06-19 A method for the treatment of senile macular retinal dystrophy

Country Status (1)

Country Link
RU (1) RU2002116180A (en)

Similar Documents

Publication Publication Date Title
DE69636085D1 (en) Use of gamma-linolenic acid or dihomogammalinolenic acid for the manufacture of a medicament for the treatment of Huntington's chorea
DE69535234D1 (en) FOR THE TREATMENT OF ALLERGIC RHINITIS AND OTHER DISEASES CONTAINING DESCARBOETHOXYLORATADIN
JP2002532432A5 (en)
WO2003011265A3 (en) 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds
ATE555782T1 (en) PREVENTION AND/OR TREATMENT OF CARDIOVASCULAR DISEASES AND/OR RELATED HEART FAILURE
Robertson et al. Uremic pruritus
WO2003026532A3 (en) Medical devices comprising nanomaterials and therapeutic methods utilizing the same
HK1103363A1 (en) Treatment of glycogen storage diseases type ii ii
WO2004004757A8 (en) Treatment for eye disorder
WO2002062385A3 (en) Method to prevent vision loss
ATE480256T1 (en) PLACENTARY ALKALINE PHOSPHATASE FOR DIABETES CONTROL
Loewenstein et al. Drug-induced retinal toxicity in albino rabbits: the effects of imipenem and aztreonam.
DE14189577T9 (en) Treatment of cystitis with high-dose chondroitin sulfate
DE59600683D1 (en) Use of trospium chloride in the manufacture of a medicament for the treatment of bladder diseases
IL130246A0 (en) Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
CA2468664A1 (en) Ketorolac tromethamine compositions for treating or preventing ocular pain
RU2002116180A (en) A method for the treatment of senile macular retinal dystrophy
CN2890976Y (en) Cornea forming contact lens
König et al. Cerebrolysin in traumatic brain injury–a pilot study of a neurotrophic and neurogenic agent in the treatment of acute traumatic brain injury
KIM et al. A clinical study of industrial ocular injuries
RU99100578A (en) METHOD FOR TREATING EYE DISEASES
Laatikainen et al. Combined use of argon laser photocoagulation and cryotherapy in the treatment of retinopathy of prematurity
RU98119433A (en) METHOD FOR TREATING CORNEAL DISEASES
JP2004315489A (en) Treatment for presbyopia and cataract, and activation of crystalline lens with eye lotion of deuterium-reduced water (super light water)
CN1224401C (en) Beri-beri medicine powder

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20060111